IHI took part in the European Cancer Meeting 2022 of the French National Cancer Institute which was held in Paris, France, on 3 to 4 February 2022. It took place at the French, Economic, Social and...

IHI took part in the European Cancer Meeting 2022 of the French National Cancer Institute which was held in Paris, France, on 3 to 4 February 2022. It took place at the French, Economic, Social and...
The document details the areas IHI should work on and guides IHI’s decisions on call topics.
Researchers from COMBACTE-CDI filled important knowledge gaps on the scale of C. diff infections, and sequenced the genomes of hundreds of strains for future researchers
Online tool allows scientists to monitor the numbers of people looking up respiratory syncytial virus (RSV) online – a useful indication of disease activity.
IMI projects are presenting results on remote clinical trials, patient information, health data, and real world evidence at the upcoming event.
UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with TB.
The AMR Accelerator is a proven model for the development of new antimicrobial drugs, experts say